Earnings Feed
Start Free
Home/Filings/4/0001161697-12-000937
4//SEC Filing

Winship M Douglas 4

Accession 0001161697-12-000937

CIK 0001369568other
View on SEC.govCompany Profile

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 5:02 PM ET

Size

9.5 KB

Accession

0001161697-12-000937

Insider Transaction Report

Form 4
Period: 2012-12-12
CATALYST PHARMACEUTICAL PARTNERS, INC.CPRX
Winship M Douglas
V.P. of Regulatory Operations
Transactions
  • Award

    Options to purchase common stock

    2012-12-12+25,000→ 312,500 total
    Exercise: $0.47From: 2012-12-12Exp: 2017-12-12→ Common Stock (25,000 underlying)
  • Award

    Options to purchase common stock

    2012-12-12+25,000→ 337,500 total
    Exercise: $0.47From: 2013-12-12Exp: 2017-12-12→ Common Stock (25,000 underlying)
  • Award

    Options to purchase common stock

    2012-12-12+25,000→ 362,500 total
    Exercise: $0.47From: 2014-12-12Exp: 2017-12-12→ Common Stock (25,000 underlying)

Documents

1 file

Issuer

CATALYST PHARMACEUTICAL PARTNERS, INC.

CIK 0001369568

→
Entity typeother

Related Parties

1
  • filerCIK 0001378683

Filing Metadata

Form type
4
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 5:02 PM ET
Size
9.5 KB
View on SEC.gov